SCLC has a lower PD-L1 expression (15%) than NSCLC (60%), since PD-L1 is mainly expressed on immune cells compared to tumor cells, and it displays an immunological microenvironment that is depleted during tumor infiltration [12,13,14]. This evidence concerns the gene CD274 and small cell lung carcinoma.